Portfolio Update

RNS Number : 5564K

Intl. Biotechnology Trust PLC

21 April 2010

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC      

Portfolio update as at 31 March 2010                                                                                     

Total Net Assets	£107.8m
NAV per share	175.4p
Share Price	139.8p
Total value of unquoted investments	£22.9m
Total number of portfolio companies	59
Cash	0%
Cash committed and reserved to unquoted investments	15%
Portfolio companies with < 1 year of cash	9%

Top Ten Holdings

Company Name	% NAV	Market Value
Micromet	7.90	8,508,263
Celgene	7.10	7,647,786
Amgen	5.82	6,273,795
Gilead Sciences	4.30	4,628,712
Shire	4.10	4,423,121
Alexion Pharmaceuticals	3.94	4,241,821
Genzyme	3.42	3,681,984
EUSA Pharma	2.87	3,088,881
Insulet	2.78	2,995,511
Oxagen	2.70	2,909,479
	-----------	--------------
Total	44.93	48,399,353

Geographical Allocation	%
United States	81
Europe	17
Cash	2
Australia	0
	-----------
Total	100

Quoted/Unquoted allocation	%
Quoted	79
Unquoted	21
Cash	0
	-----------
	100

BNP Paribas Secretarial Services Limited

Company Secretary

21 APRIL 2010

 

END

 

 

PFUBDGDSDSDBGGB